南美超级胎牛血清999尝鲜特惠
转染试剂低至5折
基质胶阶梯特惠
积分商城,好礼送不停
南美超级胎牛血清999尝鲜特惠
转染试剂低至5折
基质胶阶梯特惠
积分商城,好礼送不停
分子生物学
IVD分子诊断
细胞培养与分析
蛋白研究
细胞因子
重组蛋白
抗体
高通量测序建库
病原检测UCF系列
生物医药
工具酶
抑制剂激活剂与常用试剂
仪器
耗材

透明细胞肾细胞癌患者肠道菌群特征及促癌机制研究

Characteristics of Gut Microbiota in Patients With Clear Cell Renal Cell Carcinoma.

Yang Chen, Junjie Ma, Yunze Dong, Ziyu Yang, Na Zhao, Qian Liu, Wei Zhai, Junhua Zheng

Journal:Frontiers in Microbiology

IF:6.06

DOI:10.3389/fmicb.2022.913718

PMID:35865926

Published:2022-07-04

research field:免疫学微生物学

Abstract

Different gut microbiota is implicated in different diseases, including cancer. However, gut microbiota differences between individuals with clear cell renal cell carcinoma (ccRCC) and healthy individuals are unclear. Here, we analyzed gut microbiota composition in 51 ccRCC patients and 40 healthy controls using 16S rRNA sequencing analysis. We observed that Blautia , Streptococcus , [Ruminococcus]_torques_group , Romboutsia , and [Eubacterium]_hallii_group were dominant and positively associated with ccRCC. We isolated and cultured Streptococcus lutetiensis to characterize specific gut microbiota that promotes ccRCC and found that it promoted in vitro ccRCC proliferation, migration, and invasion via the TGF-signaling pathway. Interactions identified between the gut microbiota and ccRCC suggest the gut microbiota could serve as a potential non-invasive tool for predicting ccRCC risk and also function as a cancer therapy target.

本文使用的Yeasen产品

购物车
客服
转染试用